LEXICON PHARMACEUTICALS, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Lexicon Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2024.
  • Lexicon Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$64.8M, a 28.3% decline year-over-year.
  • Lexicon Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$216M, a 37.1% decline year-over-year.
  • Lexicon Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$177M, a 73.7% decline from 2022.
  • Lexicon Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$102M, a 16.2% decline from 2021.
  • Lexicon Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$87.8M, a 49.8% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$216M -$64.8M -$14.3M -28.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 -$202M -$53.4M -$8.53M -19% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-13
Q1 2024 -$194M -$48.4M -$16.5M -51.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-13
Q4 2023 -$177M -$49.8M -$19.3M -63.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-25
Q3 2023 -$158M -$50.5M -$27.1M -116% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$131M -$44.9M -$20.3M -82.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-13
Q1 2023 -$110M -$31.9M -$8.46M -36% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-13
Q4 2022 -$102M -$30.5M -$4.88M -19.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-25
Q3 2022 -$97.1M -$23.4M -$265K -1.15% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$96.8M -$24.6M -$6.52M -36.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-08
Q1 2022 -$90.3M -$23.5M -$2.52M -12% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-08
Q4 2021 -$87.8M -$25.6M -$20.1M -366% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-25
Q3 2021 -$67.6M -$23.1M -$106M -128% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $38.1M -$18.1M +$51M +73.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 -$12.9M -$21M +$45.7M +68.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$58.6M -$5.5M +$45.6M +89.3% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-03
Q3 2020 -$104M $82.6M -$143M -63.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $39.3M -$69.1M -$46.1M -200% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $85.3M -$66.6M -$44.8M -206% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $130M -$51.1M -$34.4M -205% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-12
Q3 2019 $164M $226M +$253M Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-30
Q2 2019 -$89M -$23M +$11.5M +33.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-29
Q1 2019 -$101M -$21.8M +$20M +47.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-27
Q4 2018 -$121M -$16.8M +$9.83M +36.9% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 -$130M -$27.4M +$2.41M +8.1% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-12
Q2 2018 -$133M -$34.5M +$108K +0.31% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-12
Q1 2018 -$133M -$41.8M -$9.9M -31% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-12
Q4 2017 -$123M -$26.6M +$5.81M +17.9% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-15
Q3 2017 -$129M -$29.8M +$6.21M +17.2% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-15
Q2 2017 -$135M -$34.7M +$3.46M +9.07% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-15
Q1 2017 -$138M -$31.9M +$2.97M +8.5% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-15
Q4 2016 -$141M -$32.4M -$119M -137% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-01
Q3 2016 -$22.3M -$36M -$733K -2.08% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-01
Q2 2016 -$21.5M -$38.1M -$10M -35.8% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-01
Q1 2016 -$11.5M -$34.9M -$6.81M -24.2% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-01
Q4 2015 -$4.68M $86.8M +$89.7M Oct 1, 2015 Dec 31, 2015 10-K 2018-03-01
Q3 2015 -$94.4M -$35.3M +$5.22M +12.9% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 -$99.6M -$28.1M -$2.05M -7.86% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 -$97.5M -$28.1M +$2.76M +8.95% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 -$100M -$2.93M +$14.5M +83.2% Oct 1, 2014 Dec 31, 2014 10-K 2015-03-12
Q3 2014 -$115M -$40.5M -$8.84M -27.9% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 -$106M -$26M +$3.05M +10.5% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 -$109M -$30.8M -$4.86M -18.7% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-05
Q4 2013 -$104M -$17.4M +$7.46M +30% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-12
Q3 2013 -$112M -$31.7M -$2.12M -7.17% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-12
Q2 2013 -$109M -$29.1M -$3.15M -12.1% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-12
Q1 2013 -$106M -$26M +$3.89M +13% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-12
Q4 2012 -$110M -$24.9M +$8.97M +26.5% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-07
Q3 2012 -$119M -$29.5M -$3.44M -13.2% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-07
Q2 2012 -$116M -$25.9M +$707K +2.65% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-07
Q1 2012 -$116M -$29.9M -$239K -0.81% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-07
Q4 2011 -$116M -$33.8M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-11
Q3 2011 -$26.1M +$1.41M +5.13% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-11
Q2 2011 -$26.6M -$1.45M -5.74% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-11
Q1 2011 -$29.6M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-11
Q3 2010 -$27.5M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-01
Q2 2010 -$25.2M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.